Longevity

KrebsfrüherkennungStudienlage & Dosis

Empfehlungen, Über-Diagnose, Galleri-Tests, Ganzkörper-MRT (kritisch).

Studienlage in Zahlen

Studien gesamt: 1.000
Mit Abstract: 40
Meta / Systematic / RCT: 1
Häufig zitiert: 5
Erscheinungsjahre: 1961–2026

Krebsfrüherkennung im Kontext von Longevity

Dieses Thema ist Teil unserer Welt „Longevity". Dort findest du Methodik, Studienlage und Hebel mit dem größten Effekt — sowie die Reihenfolge, in der sich Hebel sinnvoll aufeinander aufbauen.

Zur Welt Longevity

Top-Studien zu Krebsfrüherkennung

Sortiert nach einflussreichen Zitationen und Erscheinungsjahr.

Use of pharmacologic interventions for breast cancer risk reduction: American Society of Clinical Oncology clinical practice guideline.
J Clin Oncol2013n=19Systematic Review67 einflussreiche Zitationen
<h4>Purpose</h4>To update the 2009 American Society of Clinical Oncology guideline on pharmacologic interventions for breast cancer (BC) risk reduction.<h4>Methods</h4>A systematic review of randomized controlled trials and meta-analyses…
Screening for cervical cancer: a systematic review and meta-analysis
Systematic Reviews20135 einflussreiche Zitationen
<h4>Background</h4>The systematic review on which this paper is based provided evidence for the Canadian Task Force on Preventive Health Care to update their guideline regarding screening for cervical cancer. In this article we highlight…
Breast Cancer Screening Patterns Following National Crises: Experience from a Lebanese Tertiary Center.
Asian Pacific journal of cancer prevention : APJCP2026n=642
<h4>Background</h4>Lebanon's recent compounded crises-including economic collapse, the COVID-19 pandemic, and the Beirut Port explosion-have disrupted healthcare access, including breast cancer (BC) screening. This study assesses adherence…
Knowledge of Colorectal Cancer Risk and Cancer Screening, with Colorectal Cancer Screening Attendance: A Nationwide Study in Japan (INFORM Study, 2020).
Asian Pacific journal of cancer prevention : APJCP2026
<h4>Background</h4>Despite the availability of colorectal cancer (CRC) screening, participation rates in Japan remain low. Although knowledge about CRC has been identified as a predictor of screening uptake, data specific to the Japanese…
Reduced lung-cancer mortality with low-dose computed tomographic screening.
The New England journal of medicine2011n=100.000
<h4>Background</h4>The aggressive and heterogeneous nature of lung cancer has thwarted efforts to reduce mortality from this cancer through the use of screening. The advent of low-dose helical computed tomography (CT) altered the landscape…
Screening and Prostate-Cancer Mortality in a Randomized European Study
New England Journal of Medicine2009n=1.410
<h4>Background</h4>The European Randomized Study of Screening for Prostate Cancer was initiated in the early 1990s to evaluate the effect of screening with prostate-specific-antigen (PSA) testing on death rates from prostate…
Reduced Lung-Cancer Mortality with Volume CT Screening in a Randomized Trial
New England Journal of Medicine2020n=13
<h4>Background</h4>There are limited data from randomized trials regarding whether volume-based, low-dose computed tomographic (CT) screening can reduce lung-cancer mortality among male former and current smokers.<h4>Methods</h4>A total of…
EAU-ESTRO-SIOG Guidelines on Prostate Cancer. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent
European Urology2016
<h4>Objective</h4>To present a summary of the 2016 version of the European Association of Urology (EAU) - European Society for Radiotherapy & Oncology (ESTRO) - International Society of Geriatric Oncology (SIOG) Guidelines on screening,…
Reducing Mortality from Colorectal Cancer by Screening for Fecal Occult Blood
New England Journal of Medicine1993n=46
<h4>Background</h4>Although tests for occult blood in the feces are widely used to screen for colorectal cancers, there is no conclusive evidence that they reduce mortality from this cause. We evaluated a fecal occult-blood test in a…
Mortality Results from a Randomized Prostate-Cancer Screening Trial
New England Journal of Medicine2009n=76.693
<h4>Background</h4>The effect of screening with prostate-specific-antigen (PSA) testing and digital rectal examination on the rate of death from prostate cancer is unknown. This is the first report from the Prostate, Lung, Colorectal, and…

Häufige Fragen

Gibt es Sicherheitshinweise zu Krebsfrüherkennung?

• Adverse events were considered in the review. • Other selective ER modulators and other aromatase inhibitors are not recommended outside a clinical trial.